openPR Logo
Press release

Osteogenesis Imperfecta - Pipeline Review, H2 2018 - ResearchByMarkets.com

08-29-2018 07:19 PM CET | Health & Medicine

Press release from: Research By Markets

Osteogenesis Imperfecta - Pipeline Review, H2 2018

Osteogenesis Imperfecta - Pipeline Review, H2 2018

Osteogenesis Imperfecta - Pipeline Review, H2 2018

Summary
"Osteogenesis Imperfecta - Pipeline Review, H2 2018", provides an overview of the Osteogenesis Imperfecta (Genetic Disorders) pipeline landscape.

Osteogenesis imperfecta (OI) is a group of genetic disorders that mainly affect the bones. Mutations in the COL1A1, COL1A2, CRTAP, and P3H1 genes cause OI. An imbalance between the action of osteoclasts and osteoblasts was found in OI. Symptoms include short stature, brittle teeth, hearing loss, bone deformities and triangular-shaped face. Treatment includes medication like bisphosphonates, exercises and surgery.

Report Highlights

Osteogenesis Imperfecta - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Osteogenesis Imperfecta (Genetic Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Osteogenesis Imperfecta (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Osteogenesis Imperfecta and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 1, 1, 2 and 1 respectively.

Osteogenesis Imperfecta (Genetic Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

VIEW TOC AND LIST OF TABLES/FIGURES:
https://www.researchbymarkets.com/report/osteogenesis-imperfecta-pipeline-review-h2-2018-32975.html

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Osteogenesis Imperfecta (Genetic Disorders).
- The pipeline guide reviews pipeline therapeutics for Osteogenesis Imperfecta (Genetic Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Osteogenesis Imperfecta (Genetic Disorders) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Osteogenesis Imperfecta (Genetic Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Osteogenesis Imperfecta (Genetic Disorders)

REQUEST FOR A SAMPLE REPORT:
https://www.researchbymarkets.com/sample-request/32975

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Osteogenesis Imperfecta (Genetic Disorders).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Osteogenesis Imperfecta (Genetic Disorders) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Companies Mentioned:
Amgen Inc
Bone Therapeutics SA
Genzyme Corp
Mereo Biopharma Group Plc
Mesentech Inc
SOM Biotech SL

Get in touch with us:
ResearchByMarkets.com
Ritesh Tiwari, Director
enquiry@researchbymarkets.com
USA: +1-800-416-3124

About Us:

"Research By Markets" is a Market Research Reports Depository. Our Latest Market Research Reports cover a lot of Industry Sectors - Aerospace and Defense, Automotive and Transportation, Chemicals and Materials, Consumer Goods and Services, Energy and Power, Environmental, Food and Beverages, Healthcare, Information Technology, Manufacturing and Construction, Medical Devices, Petroleum, Pharmaceuticals, Semiconductor and Electronics, Telecommunications and more.

We are trusted by Fortune 500 companies for our client centric support. We have helped our clients in procuring research studies as per their requirements and also ensured they get proper post purchase support. We ensure that all our client queries are addressed in quick time.

We strive our best to ensure that our clients have a seamless experience and are happy and smiling every time they do business with us.

https://www.researchbymarkets.com/aboutus

Research By Markets
E/3, Ganga Homes,
Behind Bank Of India,
Viman Nagar,
Pune 411 014.
Maharashtra, India

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Osteogenesis Imperfecta - Pipeline Review, H2 2018 - ResearchByMarkets.com here

News-ID: 1210352 • Views:

More Releases from Research By Markets

V2X (Vehicle-to-Everything) Communications Ecosystem expected to grow at a CAGR of more than 170% between 2019 and 2022
V2X (Vehicle-to-Everything) Communications Ecosystem expected to grow at a CAGR …
Commonly referred to as V2X, vehicle-to-everything communications technology allows vehicles to directly communicate with each other, roadside infrastructure, and other road users to deliver an array of benefits in the form of road safety, traffic efficiency, smart mobility, environmental sustainability, and driver convenience. In addition, V2X is also helping pave the way for fully autonomous driving through its unique non line-of-sight sensing capability which allows vehicles to detect potential hazards,
Research By Markets - Trusted By Market Leaders
Research By Markets - Trusted By Market Leaders
Research By Markets is a Market Research Reports Online Repository. We have a huge database of syndicated market research reports that are segmented by Industry Verticals mainly - Telecommunication, Semiconductor, Electronics, Information Technology, Automotive, Healthcare, Pharmaceutical, Medical Devices, Biotechnology, Energy, Power, Aerospace, Defense, Consumer Goods, Construction, Equipment and many more. Our clientele includes Fortune listed companies who trust us to help them with their market intelligence requirements. Research By Markets being a
Global Veterinary Services Market: Size, Trends and Forecasts (2018-2022) - ResearchByMarkets.com
Global Veterinary Services Market: Size, Trends and Forecasts (2018-2022) - Rese …
The report titled "Global Veterinary Services Market: Size, Trends and Forecasts (2018-2022)", provides an in depth analysis of the global veterinary services market by value, by segments, by services, by region, etc. The report also provides a regional analysis of the veterinary services market, including the following regions: North America, Europe, Asia Pacific, Latin America and MEA. The report also assesses the key opportunities in the market and outlines the factors
Pancreatic and Bile Duct Cancer Drug Development Pipeline Review, 2018 - ResearchByMarkets.com
Pancreatic and Bile Duct Cancer Drug Development Pipeline Review, 2018 - Researc …
Pancreatic and Bile Duct Cancer Drug Development Pipeline Review, 2018 Summary This report provides an overview of the pipeline landscape for pancreatic and bile duct cancer. It provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for pancreatic and bile duct cancer, and features dormant and discontinued products. Pancreatic cancer is a disease in which malignant (cancer) cells are found in the tissues of the pancreas, a

All 5 Releases


More Releases for Osteogenesis

Distraction Osteogenesis Devices Market Size, Share, Development by 2024
Market Research Report Store offers a latest published report on Distraction Osteogenesis Devices Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. According to this study, over the next five years the Distraction Osteogenesis Devices market will register a 4.8% CAGR in terms of revenue, the global market size will reach US$ 214.6 million by 2024, from US$ 177.8 million in
Distraction Osteogenesis Devices Market: Competitive Dynamics & Global Outlook 2 …
Market Research Report Store offers a latest published report on Distraction Osteogenesis Devices Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Distraction Osteogenesis Devices players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Distraction Osteogenesis Devices with respect
Distraction Osteogenesis Devices Market Global Forecast to 2025
Distraction osteogenesis (DO), also called callus distraction, callotasis, osteodistraction, and distraction histogenesis is a surgical process used to reconstruct skeletal deformities and lengthen the bones of the body. As per the site of usage, DO devices can be classified as mandibular (lower law), maxillary (upper jaw), alveolar (in teeth bearing region of the jaws), palatal (roof of the mouth) or craniofacial (skull). Recent advancement such as fixator and pin design
Distraction Osteogenesis Devices Market - Increased Rising Industry Demand 2017 …
Distraction osteogenesis is a surgical technique used in oral, orthopedic, and maxillofacial surgery for treatment of various pathological conditions and skeletal deformities such as leg length discrepancy, bone deformity or bone defects also termed as callotasis, callus distraction, and osteodistraction. Distraction osteogenesis is also a treatment option for adults and children with unilateral or bilateral mandibular hypoplasia. It is also used as treatment option for widening an excessively narrow mandible.
Distraction Osteogenesis Devices Market Insights, Trends, Outlook, and Analysis, …
Distraction osteogenesis is a surgical technique used in oral, orthopedic, and maxillofacial surgery for treatment of various pathological conditions and skeletal deformities such as leg length discrepancy, bone deformity or bone defects also termed as callotasis, callus distraction, and osteodistraction. Distraction osteogenesis is also a treatment option for adults and children with unilateral or bilateral mandibular hypoplasia. It is also used as treatment option for widening an excessively narrow mandible.
Osteogenesis Imperfecta - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Osteogenesis Imperfecta - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteogenesis Imperfecta - Pipeline Review, H2 2017, provides an overview of the Osteogenesis Imperfecta (Genetic Disorders) pipeline landscape. Osteogenesis imperfecta (OI) is a genetic disorder characterized by bones that break easily, often from little or no